Status:
COMPLETED
Promethazine vs. Lorazepam for Treatment of Vertigo
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Peripheral Vertigo.
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
This study was a prospective, randomized, double-blind, parallel group clinical trial designed to compare the efficacy of intravenous (IV) promethazine and lorazepam for the treatment of peripheral ve...
Eligibility Criteria
Inclusion
- Aged 18 years or older
- Background history of positional vertigo
Exclusion
- Unable to provide informed consent
- Pregnant or possibly pregnant
- Known allergy to study medications
- Use of antiemetic agents in the previous 24 hours
- Evidence of drug-induced vertigo or orthostatic hypotension
- Central pathologies/central origin for vertigo
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT01827293
Start Date
April 1 2013
End Date
June 1 2013
Last Update
June 14 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology, Emam Hossein Hospital
Tehran, Nezam Abad, Iran, 17666-33815